“…Moving into 2021-2022, the research landscape expanded to include topics related to anticancer therapies, such as cancer therapy, and specific treatments, such as radiotherapy. The inclusion of terms like “MCF-7" suggests a focus on specific cell lines commonly used in breast cancer research [ 79 ]. Furthermore, there is evidence of a cross-disciplinary exploration of prostate cancer, indicating a broader investigation of cancer types beyond breast cancer alone [ 80 ].…”